Windamere Venture Partners specializes in seed and early-stage investments in the healthcare sector, focusing on pharmaceutical, biotechnology, and medical device companies in the United States. The firm typically participates in Series A and Series C funding rounds, demonstrating their commitment to supporting companies at various stages of growth.

Notable portfolio companies include Dexcom, a leader in continuous glucose monitoring systems, and Just Kratom Store, which has raised significant capital. Windamere's investment strategy centers on identifying innovative healthcare solutions with strong market potential. Their expertise in the healthcare sector allows them to provide valuable insights and support to their portfolio companies beyond financial investment.